| Application number | Title of the application | Filing Date | Status |
|---|
| 09/494088 | Production and use of Dopaminergic cells to treat Dopaminergic deficiencies | Jan 27, 2000 | Abandoned |
Array
(
[id] => 4311635
[patent_doc_number] => 06242254
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Recombinant cells regulated by tetracycline'
[patent_app_type] => 1
[patent_app_number] => 9/492905
[patent_app_country] => US
[patent_app_date] => 2000-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 5666
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242254.pdf
[firstpage_image] =>[orig_patent_app_number] => 492905
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/492905 | Recombinant cells regulated by tetracycline | Jan 26, 2000 | Issued |
Array
(
[id] => 754543
[patent_doc_number] => 07018979
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-03-28
[patent_title] => 'Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor'
[patent_app_type] => utility
[patent_app_number] => 09/491500
[patent_app_country] => US
[patent_app_date] => 2000-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6914
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/018/07018979.pdf
[firstpage_image] =>[orig_patent_app_number] => 09491500
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/491500 | Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor | Jan 25, 2000 | Issued |
Array
(
[id] => 4275854
[patent_doc_number] => 06323391
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration'
[patent_app_type] => 1
[patent_app_number] => 9/489979
[patent_app_country] => US
[patent_app_date] => 2000-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10084
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323391.pdf
[firstpage_image] =>[orig_patent_app_number] => 489979
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/489979 | Methods and transgenic mouse model for identifying and modulating factors leading to motor neuron degeneration | Jan 20, 2000 | Issued |
| 09/478099 | TARGETED TRANSSCLERAL CONTROLLED RELEASE DRUG DELIVERY TO THE RETINA AND CHOROID | Jan 4, 2000 | Abandoned |
| 09/472188 | DNA MOLECULE ENCODING A MUTANT PREPRO-NEUROPEPTIDE Y, A MUTANT SIGNAL PEPTIDE, AND USES THEREOF | Dec 26, 1999 | Abandoned |
Array
(
[id] => 1407526
[patent_doc_number] => 06528271
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Inhibition of arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia'
[patent_app_type] => B1
[patent_app_number] => 09/469554
[patent_app_country] => US
[patent_app_date] => 1999-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 6809
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528271.pdf
[firstpage_image] =>[orig_patent_app_number] => 09469554
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/469554 | Inhibition of arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia | Dec 21, 1999 | Issued |
Array
(
[id] => 6563621
[patent_doc_number] => 20020138855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'NON-INVASIVE EVALUATION OF PHYSIOLOGICAL RESPONSE IN A MAMMAL'
[patent_app_type] => new
[patent_app_number] => 09/464795
[patent_app_country] => US
[patent_app_date] => 1999-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29023
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20020138855.pdf
[firstpage_image] =>[orig_patent_app_number] => 09464795
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/464795 | Non-invasive evaluation of physiological response in a transgenic mouse | Dec 15, 1999 | Issued |
Array
(
[id] => 948939
[patent_doc_number] => 06962975
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-08
[patent_title] => 'Prion protein standard and method of making the same'
[patent_app_type] => utility
[patent_app_number] => 09/856230
[patent_app_country] => US
[patent_app_date] => 1999-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14373
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/962/06962975.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856230
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856230 | Prion protein standard and method of making the same | Nov 16, 1999 | Issued |
Array
(
[id] => 6650708
[patent_doc_number] => 20030008342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'SURFACE RECEPTOR ANTIGEN VACCINES'
[patent_app_type] => new
[patent_app_number] => 09/441411
[patent_app_country] => US
[patent_app_date] => 1999-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20592
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008342.pdf
[firstpage_image] =>[orig_patent_app_number] => 09441411
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/441411 | Surface receptor antigen vaccines | Nov 15, 1999 | Issued |
Array
(
[id] => 1059439
[patent_doc_number] => 06852529
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-08
[patent_title] => 'Gloucose-regulated mRNA instability element'
[patent_app_type] => utility
[patent_app_number] => 09/435471
[patent_app_country] => US
[patent_app_date] => 1999-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 49
[patent_no_of_words] => 24060
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852529.pdf
[firstpage_image] =>[orig_patent_app_number] => 09435471
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/435471 | Gloucose-regulated mRNA instability element | Nov 7, 1999 | Issued |
Array
(
[id] => 1417372
[patent_doc_number] => 06525242
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Propagation of human hepatocytes in non-human mammals'
[patent_app_type] => B1
[patent_app_number] => 09/431901
[patent_app_country] => US
[patent_app_date] => 1999-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 37
[patent_no_of_words] => 16413
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525242.pdf
[firstpage_image] =>[orig_patent_app_number] => 09431901
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/431901 | Propagation of human hepatocytes in non-human mammals | Nov 1, 1999 | Issued |
Array
(
[id] => 1261050
[patent_doc_number] => 06664039
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Methods and compositions for modulating neurodegeneration'
[patent_app_type] => B1
[patent_app_number] => 09/418963
[patent_app_country] => US
[patent_app_date] => 1999-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 18
[patent_no_of_words] => 25128
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664039.pdf
[firstpage_image] =>[orig_patent_app_number] => 09418963
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/418963 | Methods and compositions for modulating neurodegeneration | Oct 13, 1999 | Issued |
Array
(
[id] => 773297
[patent_doc_number] => 07001770
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-21
[patent_title] => 'Calpain inhibitors and their applications'
[patent_app_type] => utility
[patent_app_number] => 09/416735
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17971
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001770.pdf
[firstpage_image] =>[orig_patent_app_number] => 09416735
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/416735 | Calpain inhibitors and their applications | Oct 12, 1999 | Issued |
| 09/402911 | NOVEL PRIA | Oct 11, 1999 | Abandoned |
| 09/413785 | METHODS OF SCREENING FOR APOPTOSIS-CONTROLLING AGENTS FOR BONE ANABOLIC THERAPIES AND USES THEREOF | Oct 6, 1999 | Abandoned |
| 09/319236 | THERAPEUTIC COMPOSITION COMPRISING THE KAL PROTEIN AND USE OF THE KAL PROTEIN FOR THE TREATMENT OF RETINAL, RENAL, NEURONAL AND NEURAL INJURY | Sep 1, 1999 | Abandoned |
Array
(
[id] => 948653
[patent_doc_number] => 06962688
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-08
[patent_title] => 'Methods for modulation of cholesterol transport'
[patent_app_type] => utility
[patent_app_number] => 09/385799
[patent_app_country] => US
[patent_app_date] => 1999-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10477
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/962/06962688.pdf
[firstpage_image] =>[orig_patent_app_number] => 09385799
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/385799 | Methods for modulation of cholesterol transport | Aug 29, 1999 | Issued |
Array
(
[id] => 4322721
[patent_doc_number] => 06331525
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Targeted delivery of genes encoding interferon'
[patent_app_type] => 1
[patent_app_number] => 9/379434
[patent_app_country] => US
[patent_app_date] => 1999-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 11029
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331525.pdf
[firstpage_image] =>[orig_patent_app_number] => 379434
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/379434 | Targeted delivery of genes encoding interferon | Aug 22, 1999 | Issued |
| 09/374742 | METHODS AND COMPOSITIONS FOR BISUBSTRATE INHIBITORS OF ACETYLTRANSFERASES | Aug 12, 1999 | Abandoned |